Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | S100A4 | P26447 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | MAOA | P21397 | 4/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.42 |
| ▸ | HPGD | P15428 | 3/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 3/20 | 0.42 |
| ▸ | GAA | P10253 | 3/20 | 0.42 |
| ▸ | GLA | P06280 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | HTT | P42858 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | PGAM1 | P18669 | 1/20 | 0.42 |
| ▸ | CASP1 | P29466 | 1/20 | 0.42 |
| ▸ | CASP7 | P55210 | 1/20 | 0.42 |
| ▸ | POLB | P06746 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29713419 | 0.94 | S100A4 (0.48) | S100A4ALDH1A1MAOASMN1; SMN2HPGD | |
| SCHEMBL29425353 | 0.94 | S100A4 (0.48) | S100A4ALDH1A1MAOASMN1; SMN2HPGD | |
| SCHEMBL470784 | 0.94 | S100A4 (0.48) | S100A4ALDH1A1MAOASMN1; SMN2HPGD | |
| SCHEMBL30019620 | 0.94 | S100A4 (0.48) | S100A4ALDH1A1MAOASMN1; SMN2HPGD | |
| SCHEMBL11049489 | 0.94 | S100A4 (0.48) | S100A4ALDH1A1MAOASMN1; SMN2HPGD | |
| SCHEMBL25234735 | 0.94 | S100A4 (0.48) | S100A4ALDH1A1MAOASMN1; SMN2HPGD | |
| SCHEMBL7905111 | 0.94 | S100A4 (0.52) | S100A4ALDH1A1MAOASMN1; SMN2HPGD | |
| SCHEMBL20669039 | 0.89 | S100A4 (0.42) | S100A4ALDH1A1MAOASMN1; SMN2HPGD | |
| SCHEMBL20669045 | 0.88 | S100A4 (0.48) | S100A4ALDH1A1MAOASMN1; SMN2HPGD | |
| SCHEMBL20668931 | 0.86 | S100A4 (0.43) | S100A4ALDH1A1MAOASMN1; SMN2HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3211058-B1 | NEW MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2023-08-23 | — | — | EP | disclosed |
| EP-3211058-A1 | NEW MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | Merck Patent GmbH (DE) | 2017-08-30 | — | — | EP | disclosed |
| US-8748010-B2 | Materials for organic electroluminescent devices | MERCK PATENT GMBH (DE) | 2014-06-10 | — | — | US | disclosed |
| US-20080193797-A1 | Novel Materials for Organic Electroluminescent Devices | MERCK PATENT GMBH (DE) | 2008-08-14 | — | — | US | disclosed |
| EP-1917323-A1 | NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | Merck Patent GmbH (DE) | 2008-05-07 | — | — | EP | disclosed |
| WO-2007022845-A1 | NOVEL MATERIALS FOR ORGANIC ELECTROLUMINESCENT DEVICES | MERCK PATENT GMBH (DE) | 2007-03-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080193797-A1 | Novel Materials for Organic Electroluminescent Devices | SLC40A1, SLC67A1, SLC29A1 | S100A4 138/4885ALDH1A1 356/4885MAOA 994/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.